OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
73 hedge funds and large institutions have $35.1M invested in Orexigen Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 33 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 40
77% less call options, than puts
Call options by funds: $25K | Put options by funds: $109K
Holders
73
Holding in Top 10
1
Calls
$25K
Puts
$109K
Top Buyers
| 1 | +$2.26M | |
| 2 | +$340K | |
| 3 | +$260K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$79.6K |
| 5 |
Squarepoint
New York
|
+$77K |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$14.4M | |
| 3 | -$4.17M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.3M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.47M |